Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant

Uses

Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant is used to prevent cervical cancer.

How it Works

How Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant Works Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant is a vaccine that helps develop immunity by initiating a mild infection. This type of infection does not cause illness, but it stimulates the body's immune system to produce antibodies that protect against future infections.

Side Effects

Common side effects of the Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant include joint pain, headache, vomiting, fever, dizziness, nausea, diarrhea, injection site reactions (pain, swelling, redness), upper respiratory tract infection, general discomfort, sleepiness, nasal congestion, joint inflammation, and arthropathy.

Expert Advice

  • Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant is used for the prevention of cervical cancer.
  • It does not cure an existing HPV infection but can protect against other strains of HPV.
  • The vaccine is usually administered via injection into the muscle of the upper arm.
  • Remain seated for at least 15 minutes after the injection, as it may cause dizziness or fainting.
  • This vaccine does not protect against every type of HPV.
  • Take precautions against sexually transmitted diseases and follow your doctor’s advice.
  • Consult with your doctor if you forget to take a scheduled dose.

Other Combinations

Frequently asked questions

Yes, using condoms does not provide complete protection against HPV, as the virus can still be transmitted through skin-to-skin contact during sexual activities.
The vaccine is highly effective, providing nearly 100% protection against cervical cancer and infections from HPV types 16 and 18, as shown in clinical trials.
The Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant is used to prevent cervical cancer in females by protecting against infections caused by HPV types 16 and 18.
Side effects are generally mild and may include soreness, swelling, or redness at the injection site, dizziness, fainting, headaches, nausea, vomiting, fatigue, or weakness.
The vaccine is recommended for adolescent girls aged 11 to 12 years, and for all females aged 13 to 26 who missed vaccination earlier. It can be administered to females aged 9 to 45, with dosage and schedule depending on age.
Yes, the vaccine is effective even if you have had sexual intercourse. It protects against multiple HPV strains, so you can still benefit from vaccination even if you have one strain.
Yes, regular cervical cancer screenings are still necessary as the vaccine does not protect against all HPV types that can cause cervical cancer.
No, you can continue from where you left off. The recommended schedule includes three doses, and if a dose is delayed, you do not need to restart the series.
;